Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1080/10550490701861177

http://scihub22266oqcxt.onion/10.1080/10550490701861177
suck pdf from google scholar
18393061/?report=reader!2733248!18393061
unlimited free pdf from europmc18393061    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid18393061      Am+J+Addict 2008 ; 17 (2): 161-4
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Use of dronabinol for cannabis dependence: two case reports and review #MMPMID18393061
  • Levin FR; Kleber HD
  • Am J Addict 2008[Mar]; 17 (2): 161-4 PMID18393061show ga
  • Marijuana is the most commonly used illicit drug in the United States and throughout the world. Despite this, the number of laboratory studies that have assessed pharmacologic agents to target cannabis withdrawal symptoms or reduce the reinforcing effects of marijuana has been modest. Unlike alcohol, cocaine, opiates, or nicotine, there has been a minimal number of clinical pharmacologic treatment trials that have targeted marijuana use. Based on recent laboratory studies, dronabinol (delta-9-tetrahydrocannabinol) has been shown to reduce cannabis withdrawal symptoms and the subjective effects of marijuana. Given that agonist agents have been found to be effective for opiate and nicotine dependence, the clinical utility of dronabinol for cannabis dependence is a reasonable approach. Two case reports using dronabinol are presented. The potential benefit, as well as questions that arise from the use of this medication in cannabis-abusing populations, is presented. Also, future areas of research that might be explored are discussed.
  • |Adult[MESH]
  • |Alcoholism/diagnosis/psychology/rehabilitation[MESH]
  • |Ambulatory Care[MESH]
  • |Benzhydryl Compounds/administration & dosage/adverse effects[MESH]
  • |Cannabinoids/*toxicity[MESH]
  • |Comorbidity[MESH]
  • |Dose-Response Relationship, Drug[MESH]
  • |Dronabinol/*administration & dosage/adverse effects[MESH]
  • |Drug Administration Schedule[MESH]
  • |Drug Therapy, Combination[MESH]
  • |Follow-Up Studies[MESH]
  • |Humans[MESH]
  • |Male[MESH]
  • |Marijuana Abuse/diagnosis/psychology/*rehabilitation[MESH]
  • |Modafinil[MESH]
  • |Psychotropic Drugs/*administration & dosage/adverse effects[MESH]
  • |Substance Withdrawal Syndrome/diagnosis/psychology/*rehabilitation[MESH]
  • |Treatment Outcome[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box